CANY
DVAX

Caxton Associates (New York)’s Dynavax Technologies DVAX Stock Holding History

Caxton Associates (New York)’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,960
Closed -$268K – 581
2021
Q3 		$268K Buy
+13,960
New +$185K 0.03% 342
2020
Q3 		– Sell
-24,348
Closed -$216K – 364
2020
Q2 		$216K Buy
+24,348
New +$123K 0.02% 354

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caxton Associates (New York)'s DVAX Position: Q4 2021 in Review

Caxton Associates (New York) sold out of Dynavax Technologies (DVAX) in Q4 2021, closing a stake of 13,960 shares — an estimated $268K sold.

Caxton Associates (New York) first reported a position in DVAX in Q2 2020 and held it in 2 quarters. The position peaked at $268K in Q3 2021. 200 funds tracked by Wall St. Rank hold DVAX as of Q4 2021.

  • Caxton Associates (New York) reported no remaining Dynavax Technologies position as of Q4 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 13,960 Dynavax Technologies shares in Q4 2021, an estimated $268K.
  • Caxton Associates (New York) first reported a position in Dynavax Technologies in Q2 2020 and held it in 2 quarters.
  • Caxton Associates (New York)'s Dynavax Technologies position peaked at $268K in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2021.

Based on Caxton Associates (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.